Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 02, 2021 Filed Dec 3, 2021 21:22 UTC |
DIXON WENDY LDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 5,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-030301 · form4.xml · derivative · entry 3 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 21:22 UTC |
DIXON WENDY LDirector
|
Tax withholdingOrdinary Shares | 1,339 | $22.11 | $29,605.29 |
DisclosureSEC source: 0001127602-21-030301 · form4.xml · nonDerivative · entry 2 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,539 Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 21:22 UTC |
DIXON WENDY LDirector
|
Exercise / conversionOrdinary Shares | 5,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-030301 · form4.xml · nonDerivative · entry 1 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| December 02, 2021 Filed Dec 4, 2021 02:26 UTC |
snyderman nancy lynn MDDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 5,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-030303 · form4.xml · derivative · entry 3 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| December 02, 2021 Filed Dec 4, 2021 02:26 UTC |
snyderman nancy lynn MDDirector
|
Tax withholdingOrdinary Shares | 1,339 | $22.11 | $29,605.29 |
DisclosureSEC source: 0001127602-21-030303 · form4.xml · nonDerivative · entry 2 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,939 Read SEC document |
| December 02, 2021 Filed Dec 4, 2021 02:26 UTC |
snyderman nancy lynn MDDirector
|
Exercise / conversionOrdinary Shares | 5,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-030303 · form4.xml · nonDerivative · entry 1 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| December 02, 2021 Filed Dec 4, 2021 02:24 UTC |
GAYNOR RICHARDDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 5,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-030302 · form4.xml · derivative · entry 3 GAYNOR RICHARD · CIK 0001741284 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| December 02, 2021 Filed Dec 4, 2021 02:24 UTC |
GAYNOR RICHARDDirector
|
Tax withholdingOrdinary Shares | 1,339 | $22.11 | $29,605.29 |
DisclosureSEC source: 0001127602-21-030302 · form4.xml · nonDerivative · entry 2 GAYNOR RICHARD · CIK 0001741284 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,939 Read SEC document |
| December 02, 2021 Filed Dec 4, 2021 02:24 UTC |
GAYNOR RICHARDDirector
|
Exercise / conversionOrdinary Shares | 5,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-030302 · form4.xml · nonDerivative · entry 1 GAYNOR RICHARD · CIK 0001741284 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| December 02, 2021 Filed Dec 4, 2021 02:11 UTC |
Cooke ShaneDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 5,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-030297 · form4.xml · derivative · entry 3 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| December 02, 2021 Filed Dec 4, 2021 02:11 UTC |
Cooke ShaneDirector
|
Tax withholdingOrdinary Shares | 2,901 | $22.11 | $64,141.11 |
DisclosureSEC source: 0001127602-21-030297 · form4.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,478 Read SEC document |
| December 02, 2021 Filed Dec 4, 2021 02:11 UTC |
Cooke ShaneDirector
|
Exercise / conversionOrdinary Shares | 5,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-030297 · form4.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,379 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 20:32 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Tax withholdingOrdinary Shares | 36,267 | $30.60 | $1,109,770.20 |
DisclosureSEC source: 0001127602-21-025409 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 837,455 Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 20:32 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
GrantOrdinary Shares | 81,682 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025409 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 873,722 F1 · price: These ordinary shares were acquired by the reporting person as a result of the partial vesting of performance-vesting restricted stock unit awards ("PRSUs") granted to the reporting person on February 20, 2020. The vesting of this portion of the PRSUs was triggered by the achievement of certain pre-specified pipeline performance goals. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 20:31 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Tax withholdingOrdinary Shares | 4,608 | $30.60 | $141,004.80 |
DisclosureSEC source: 0001127602-21-025406 · form4.xml · nonDerivative · entry 2 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,538 Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 20:31 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
GrantOrdinary Shares | 15,672 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025406 · form4.xml · nonDerivative · entry 1 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,146 F1 · price: These ordinary shares were acquired by the reporting person as a result of the partial vesting of performance-vesting restricted stock unit awards ("PRSUs") granted to the reporting person on February 20, 2020. The vesting of this portion of the PRSUs was triggered by the achievement of certain pre-specified pipeline performance goals. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 16:28 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 3,566 | $30.60 | $109,119.60 |
DisclosureSEC source: 0001127602-21-025405 · form4.xml · nonDerivative · entry 2 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,246 Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 16:28 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
GrantOrdinary Shares | 8,031 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025405 · form4.xml · nonDerivative · entry 1 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,812 F1 · price: These ordinary shares were acquired by the reporting person as a result of the partial vesting of performance-vesting restricted stock unit awards ("PRSUs") granted to the reporting person on February 20, 2020. The vesting of this portion of the PRSUs was triggered by the achievement of certain pre-specified pipeline performance goals. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 20:26 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Tax withholdingOrdinary Shares | 2,024 | $30.60 | $61,934.40 |
DisclosureSEC source: 0001127602-21-025404 · form4.xml · nonDerivative · entry 2 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,014 Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 20:26 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
GrantOrdinary Shares | 6,884 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025404 · form4.xml · nonDerivative · entry 1 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,038 F1 · price: These ordinary shares were acquired by the reporting person as a result of the partial vesting of performance-vesting restricted stock unit awards ("PRSUs") granted to the reporting person on February 20, 2020. The vesting of this portion of the PRSUs was triggered by the achievement of certain pre-specified pipeline performance goals. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 20:25 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Tax withholdingOrdinary Shares | 5,647 | $30.60 | $172,798.20 |
DisclosureSEC source: 0001127602-21-025401 · form4.xml · nonDerivative · entry 2 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,496 Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 20:25 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
GrantOrdinary Shares | 15,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025401 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,143 F1 · price: These ordinary shares were acquired by the reporting person as a result of the partial vesting of performance-vesting restricted stock unit awards ("PRSUs") granted to the reporting person on February 20, 2020. The vesting of this portion of the PRSUs was triggered by the achievement of certain pre-specified pipeline performance goals. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 20:23 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 4,634 | $30.60 | $141,800.40 |
DisclosureSEC source: 0001127602-21-025400 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,518 Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 20:23 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
GrantOrdinary Shares | 10,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025400 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,152 F1 · price: These ordinary shares were acquired by the reporting person as a result of the partial vesting of performance-vesting restricted stock unit awards ("PRSUs") granted to the reporting person on February 20, 2020. The vesting of this portion of the PRSUs was triggered by the achievement of certain pre-specified pipeline performance goals. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 20:21 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 3,057 | $30.60 | $93,544.20 |
DisclosureSEC source: 0001127602-21-025399 · form4.xml · nonDerivative · entry 2 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,807 Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 20:21 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
GrantOrdinary Shares | 6,884 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025399 · form4.xml · nonDerivative · entry 1 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,864 F1 · price: These ordinary shares were acquired by the reporting person as a result of the partial vesting of performance-vesting restricted stock unit awards ("PRSUs") granted to the reporting person on February 20, 2020. The vesting of this portion of the PRSUs was triggered by the achievement of certain pre-specified pipeline performance goals. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 20:48 UTC |
Alva Emily PetersonDirector
|
PurchaseOrdinary Shares | 1,650.165 | $30.22 | $49,860.40 |
DisclosureSEC source: 0001127602-21-024274 · form4.xml · nonDerivative · entry 1 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,650.165 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $30.21 to $30.2199. Full information regarding the number of shares purchased at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 20:22 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-21-024109 · form4.xml · derivative · entry 3 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 40,000 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 20:22 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
SaleOrdinary Shares | 40,000 | $29.99 | $1,199,600.00 |
DisclosureSEC source: 0001127602-21-024109 · form4.xml · nonDerivative · entry 2 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,980 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 20:22 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 40,000 | $16.55 | $662,000.00 |
DisclosureSEC source: 0001127602-21-024109 · form4.xml · nonDerivative · entry 1 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,980 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Since the date of the reporting person's last ownership report, the reporting person transferred 5,382 ordinary shares to his former spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his former spouse. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:46 UTC |
MCKEON BRIAN PDirector
|
PurchaseOrdinary Shares | 10,000 | $26.43 | $264,269.00 |
DisclosureSEC source: 0001127602-21-023084 · form4.xml · nonDerivative · entry 1 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Brian P. McKeon Trust Disclosed balance after: 10,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $26.41 to $26.44. Full information regarding the number of shares purchased at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. F2 · ownership.nature: The reporting person and his wife are trustees of The Brian P. McKeon Revocable Trust, dated April 12, 2007 and amended and restated on February 8, 2019 (the "Brian P. McKeon Trust"), and members of the reporting person's immediate family are beneficiaries of the trust. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 20:20 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-21-022637 · form4.xml · derivative · entry 3 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 14,000 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 20:20 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
SaleOrdinary Shares | 14,000 | $26.00 | $364,000.00 |
DisclosureSEC source: 0001127602-21-022637 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,597 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 20:20 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 14,000 | $16.55 | $231,700.00 |
DisclosureSEC source: 0001127602-21-022637 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 16:19 UTC |
ANSTICE DAVID WDirector
|
Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $14.60 | $0.00 |
DisclosureSEC source: 0001127602-21-021239 · form4.xml · derivative · entry 3 ANSTICE DAVID W · CIK 0001181171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 20,000 shares Expires 2021-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 16:19 UTC |
ANSTICE DAVID WDirector
|
SaleOrdinary Shares | 20,000 | $24.58 | $491,504.00 |
DisclosureSEC source: 0001127602-21-021239 · form4.xml · nonDerivative · entry 2 ANSTICE DAVID W · CIK 0001181171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,081 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.48 to $24.73. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 16:19 UTC |
ANSTICE DAVID WDirector
|
Exercise / conversionOrdinary Shares | 20,000 | $14.60 | $292,000.00 |
DisclosureSEC source: 0001127602-21-021239 · form4.xml · nonDerivative · entry 1 ANSTICE DAVID W · CIK 0001181171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 16:19 UTC |
ANSTICE DAVID WDirector
|
GrantRestricted Stock Unit Award · Derivative | 7,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020033 · form4.xml · derivative · entry 2 ANSTICE DAVID W · CIK 0001181171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 Underlying: Ordinary Shares · 7,585 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 16:19 UTC |
ANSTICE DAVID WDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 15,677 | $0.00 Strike: $24.72 | $0.00 |
DisclosureSEC source: 0001127602-21-020033 · form4.xml · derivative · entry 1 ANSTICE DAVID W · CIK 0001181171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,677 Underlying: Ordinary Shares · 15,677 shares Expires 2031-06-14 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 16:17 UTC |
Alva Emily PetersonDirector
|
GrantRestricted Stock Unit Award · Derivative | 7,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020032 · form4.xml · derivative · entry 2 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 Underlying: Ordinary Shares · 7,585 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 16:17 UTC |
Alva Emily PetersonDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 15,677 | $0.00 Strike: $24.72 | $0.00 |
DisclosureSEC source: 0001127602-21-020032 · form4.xml · derivative · entry 1 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,677 Underlying: Ordinary Shares · 15,677 shares Expires 2031-06-14 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:29 UTC |
Wilson Frank AndersDirector
|
GrantRestricted Stock Unit Award · Derivative | 7,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020047 · form4.xml · derivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 Underlying: Ordinary Shares · 7,585 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:29 UTC |
Wilson Frank AndersDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 15,677 | $0.00 Strike: $24.72 | $0.00 |
DisclosureSEC source: 0001127602-21-020047 · form4.xml · derivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,677 Underlying: Ordinary Shares · 15,677 shares Expires 2031-06-14 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:30 UTC |
Wysenski NancyDirector
|
GrantRestricted Stock Unit Award · Derivative | 7,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020049 · form4.xml · derivative · entry 2 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 Underlying: Ordinary Shares · 7,585 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:30 UTC |
Wysenski NancyDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 15,677 | $0.00 Strike: $24.72 | $0.00 |
DisclosureSEC source: 0001127602-21-020049 · form4.xml · derivative · entry 1 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,677 Underlying: Ordinary Shares · 15,677 shares Expires 2031-06-14 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 16:25 UTC |
DIXON WENDY LDirector
|
GrantRestricted Stock Unit Award · Derivative | 7,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020042 · form4.xml · derivative · entry 2 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 Underlying: Ordinary Shares · 7,585 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 16:25 UTC |
DIXON WENDY LDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 15,677 | $0.00 Strike: $24.72 | $0.00 |
DisclosureSEC source: 0001127602-21-020042 · form4.xml · derivative · entry 1 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,677 Underlying: Ordinary Shares · 15,677 shares Expires 2031-06-14 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:27 UTC |
MCKEON BRIAN PDirector
|
GrantRestricted Stock Unit Award · Derivative | 7,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020045 · form4.xml · derivative · entry 2 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 Underlying: Ordinary Shares · 7,585 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:27 UTC |
MCKEON BRIAN PDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 15,677 | $0.00 Strike: $24.72 | $0.00 |
DisclosureSEC source: 0001127602-21-020045 · form4.xml · derivative · entry 1 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,677 Underlying: Ordinary Shares · 15,677 shares Expires 2031-06-14 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:28 UTC |
snyderman nancy lynn MDDirector
|
GrantRestricted Stock Unit Award · Derivative | 7,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020046 · form4.xml · derivative · entry 2 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 Underlying: Ordinary Shares · 7,585 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.